We reported that this paracrine two-cell type (myeloid cell—fibroblasts) negative feedback loop mechanism may contribute to a novel adenosinergic mechanism of TGFβ regulation in the tumor microenvironment and represents a potential therapeutic target. The gene discussed is TGFB1; the disease is neoplasm.